Preliminary Results of the First-in-Human, Dose-Finding PROCLAIM-CX-072 Trial Evaluating the PD-L1 Probody Therapeutic CX-072 in Combination With Ipilimumab in Patients With Advanced Solid Tumors

Ruth Plummer, Rachel E. Sanborn, Elisabeth de Vries, Patricia LoRusso,Hendrik-Tobias Arkenau, Nataliya Uboha, Jerzy Wydmanski, Mary Josephine Fidler, Valentina Boni, Javier Garcia-Corbacho, Rachel Humphrey, Matthias Will, Karen A. Autio, Anthony El-Khoueiry, C. Willemien Menke-van der Houven van Oordt, Fiona Thistlethwaite. Poster presented at ESMO 2018, October 19-23, Munich, Germany.